JOURNAL ARTICLE

Phase I Trial of Sunitinib Plus Imatinib in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

Keywords:
Medicine Sunitinib GiST Imatinib Internal medicine Oncology Stromal tumor Stromal cell Imatinib mesylate Cancer

Metrics

0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
0.42
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Topics

Gastrointestinal Tumor Research and Treatment
Health Sciences →  Medicine →  Gastroenterology
Pancreatic and Hepatic Oncology Research
Health Sciences →  Medicine →  Oncology
Chronic Myeloid Leukemia Treatments
Health Sciences →  Medicine →  Hematology

Related Documents

JOURNAL ARTICLE

The Efficacy of Imatinib in Unresectable/Metastatic Gastrointestinal Stromal Tumors

Shreyaskumar PatelPatrick WongTechnical Editor, Touch Briefings

Journal:   touchREVIEWS in Oncology & Haematology Year: 2009 Vol: 05 (01)Pages: 61-61
© 2026 ScienceGate Book Chapters — All rights reserved.